To assist us in evaluating the effectiveness of this activity, please complete the following pretest. You will be redirected to the Zoom meeting upon submission.

Question Title

* 1. Which of the following best describes your profession?

Question Title

* 2. Which of the following best describes your specialty?

Question Title

* 3. How confident are you in the management of patients with atopic dermatitis (AD) in your practice? 

Question Title

* 4. Which of the following is most important for pediatric nurse practitioners (PNPs) to understand in order to diagnose AD in children?  

Question Title

* 5. It is critical for PNPs to be familiar with biologics and small-molecule treatments that are FDA approved for AD because of which of the following?

Question Title

* 6. Which of the following is the hallmark of severe-to-moderate AD?

Question Title

* 7. Mrs. Williams brings her daughter, 4-year-old Mia, into the clinic to be seen by a PNP. She complains that the topical medication that was prescribed for Mia for severe AD 6 weeks ago does not appear to be working as the rash is getting worse. Medical history reveals that Mia is also allergic to tree nuts and has allergic rhinitis. What should the PNP do?

Question Title

* 8. A PNP recommends a systemic treatment for Elijah, an 8-month-old infant with severe AD. In terms of safety, which of the following systemic treatments that have been approved by the FDA for pediatric populations would be the most appropriate choice?

Question Title

* 9. Treatment adherence can be enhanced by establishing therapeutic goals and doing which of the following?   

Question Title

* 10. Noah, an 18-month-old toddler with severe AD, was prescribed dupilumab by an AD specialist. What should the PNP who is managing this patient do to monitor for potential adverse events?

T